Jotec Gmbh
Clinical trials sponsored by Jotec Gmbh, explained in plain language.
-
New stent graft aims to prevent deadly aneurysm ruptures
Disease control OngoingThis study looks at a special stent graft designed to treat a dangerous bulge in the main artery of the chest and belly (thoracoabdominal aortic aneurysm). The goal is to prevent death from the aneurysm. About 150 adults aged 18 to 85 with this condition will receive the device, …
Sponsor: JOTEC GmbH • Aim: Disease control
Last updated Jun 16, 2026 12:51 UTC
-
New stent registry aims to improve aortic dissection outcomes
Disease control OngoingThis study is a registry that collects information on the AMDS stent, a device used to treat a life-threatening tear in the aorta (the main artery). The registry includes 301 adults aged 18-80 with acute DeBakey type I aortic dissection or intramural hematoma. The goal is to see …
Sponsor: JOTEC GmbH • Aim: Disease control
Last updated Jun 09, 2026 12:08 UTC
-
New stent graft tested for Life-Threatening aortic aneurysms
Disease control OngoingThis study follows 30 people with thoracoabdominal aortic aneurysms (a bulging, weakened area in the main artery) who received a special stent graft called E-nside. The goal is to see if the device is safe and works well over time. Researchers will track deaths, ruptures, and oth…
Sponsor: JOTEC GmbH • Aim: Disease control
Last updated Jun 08, 2026 13:06 UTC